Showing results (1711-1720 of 2,084) with videos related to

Sort By:
Pageof 209
Clinical Genetics|December 21, 2013
Molecular analyses of novel ASAH1 mutations causing Farber lipogranulomatosis: analyses of exonic splicing enhancer inactivating mutationM D Bashyam, A K Chaudhary, M Kiran, et al.
Materials (Basel, Switzerland)|June 2, 2021
Melatonin as a Topical/Systemic Formulation for the Management of Periodontitis: A Systematic ReviewThodur Madapusi Balaji, Saranya Varadarajan, Raghunathan Jagannathan, et al.
Pediatric Hematology and Oncology|February 27, 2019
Aggressive embryonal rhabdomyosarcoma in a 3-month-old boy: A clinical and molecular analysisSamuele Renzi, Karin Langenberg-Ververgaert, Fabio Fuligni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2014
DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanomaA Gupta, S Love, A Schuh, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Is Palatal Rugae Pattern a Reliable Tool for Personal Identification following Orthodontic Treatment? A Systematic Review and Meta-AnalysisArchana A Gupta, Supriya Kheur, Abdulrahman Alshehri, et al.
Chemical Science|June 4, 2021
Dynamic design: manipulation of millisecond timescale motions on the energy landscape of cyclophilin AJordi Juárez-Jiménez, Arun A Gupta, Gogulan Karunanithy, et al.
Cancer Research|February 24, 2001
15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cellsS B Shappell, R A Gupta, S Manning, et al.
Physical Review Letters|September 26, 2012
Observations of Co4+ in a higher spin state and the increase in the Seebeck coefficient of thermoelectric Ca3Co4O9R F Klie, Q Qiao, T Paulauskas, et al.
Disease Models & Mechanisms|January 18, 2024
Standardization of zebrafish drug testing parameters for muscle diseasesMuthukumar Karuppasamy, Katherine G English, Clarissa A Henry, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 30, 2015
A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas-NCIC-CTG IND 200†Q S-C Chu, T O Nielsen, T Alcindor, et al.
Pageof 209